Skip to main content

Open Access Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol

Download Article:
 Download
(PDF 200.5537109375 kb)
 
Patients suffering from cystic fibrosis (CF) often need to inhale multiple doses of different nebulizable drugs per day. Patients attempt to shorten the time consuming administration procedure by mixing drug solutions/suspensions for simultaneous inhalation. The objective of this experimental study was to determine whether mixtures of Pulmozyme® inhalation solution with Atrovent® or Sultanol® are physicochemically compatible. Drug combinations were prepared in accordance with the product information and clinical practice by mixing the content of one respule Pulmozyme® with 2 mL Atrovent® LS and 0.5 mL Sultanol® Inhalationslösung (inhalation solution) or with one respule of either Atrovent® 500 μg/2 mL Fertiginhalat (unit dose formulation) or Sultanol® forte Fertiginhalat. Test solutions were stored at room temperature and exposed to light. Dornase alfa activity was determined by a kinetic colorimetric DNase activity assay. Ipratropium bromide and albuterol concentrations were investigated by a stability-indicating HPLC assay with ultraviolet detection. Physical compatibility was determined by visual inspection and measurements of pH and osmolality. Ipratropium bromide and albuterol concentrations were not affected by mixing the drug products. Dornase alfa activity is affected by benzalkonium chloride, used as excipient in Atrovent® LS and Sultanol® Inhalationslösung, and disodium edetate used as an excipient in Atrovent® LS. Patients should be advised not to mix Pulmozyme® with Atrovent® LS and/or Sultanol® Inhalationslösung, because of the incompatibility reaction. Mixtures of Pulmozyme® with Atrovent® 500 μg/2 mL Fertiginhalat or Sultanol® forte Fertiginhalat can be designated as compatible for a limited period of time.
No References for this article.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Affiliations: 1: Department of Pharmacy, Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, Mainz, 55101, Germany, Email: Kraemer@apotheke.klinik.uni-mainz.de 2: Department of Pharmacy, Johannes Gutenberg-Universität Mainz, Mainz, Germany 3: Department of Clinical Chemistry, Medizinische Hochschule Hannover, Hannover, Germany 4: Childrens Hospital, Johannes Gutenberg-Universität Mainz, Mainz, Germany

Publication date: 2007-10-01

More about this publication?
  • Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more